CD26 inhibition and hematopoiesis: A novel approach to enhance transplantation

Timothy B. Campbel, Hal Broxmeyer

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Dipeptidylpeptidase IV/CD26 is expressed on the surface of various cell types. Through its enzymatic activity, its major function is to cleave the N-terminal dipeptide from diverse molecules including members of the chemokine family of cytokines. The N-terminus of these chemokines is important for activation of and binding to seven-transmembrane G-protein linked chemokine receptors, and early studies showed truncation by CD26 physiologically alters these properties of select chemokines resulting in diverse functional outcomes. Stromal-derived factor-1 (SDF-1/CXCL12), a chemokine involved in hematopoietic cell Chemotaxis, homing, mobilization and survival, is cleaved by CD26 producing a form that is inactive in CXCR4 signaling and has some antagonistic properties in vitro. Recent studies have shown that the inhibition of cell-surface CD26 peptidase activity on hematopoietic stem/progenitor cell (HSC/HPC) populations increases their SDF-1/CXCL12 directed chemotaxis in vitro, and in vivo homing and engraftment. CD26 inhibition may, therefore, represent a novel approach to increasing the efficacy and success of HSC/HPC transplantation, especially under conditions of limiting donor cell yield.

Original languageEnglish
Pages (from-to)1795-1805
Number of pages11
JournalFrontiers in Bioscience
Volume13
Issue number5
DOIs
StatePublished - 2008

Fingerprint

Hematopoiesis
Chemokines
Transplantation
Chemotaxis
Hematopoietic Stem Cells
Chemokine CXCL12
Dipeptides
Chemokine Receptors
Stem cells
GTP-Binding Proteins
Peptide Hydrolases
Chemical activation
Cells
Cytokines
Molecules
Inhibition (Psychology)
Population
In Vitro Techniques

Keywords

  • CD26
  • CXCL12
  • CXCR4
  • Hematopoietic stem cells
  • Review
  • SDF-1
  • Transplantation

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Biochemistry
  • Cell Biology
  • Medicine(all)

Cite this

CD26 inhibition and hematopoiesis : A novel approach to enhance transplantation. / Campbel, Timothy B.; Broxmeyer, Hal.

In: Frontiers in Bioscience, Vol. 13, No. 5, 2008, p. 1795-1805.

Research output: Contribution to journalArticle

@article{20a3f501149944848108cd714c3e95d1,
title = "CD26 inhibition and hematopoiesis: A novel approach to enhance transplantation",
abstract = "Dipeptidylpeptidase IV/CD26 is expressed on the surface of various cell types. Through its enzymatic activity, its major function is to cleave the N-terminal dipeptide from diverse molecules including members of the chemokine family of cytokines. The N-terminus of these chemokines is important for activation of and binding to seven-transmembrane G-protein linked chemokine receptors, and early studies showed truncation by CD26 physiologically alters these properties of select chemokines resulting in diverse functional outcomes. Stromal-derived factor-1 (SDF-1/CXCL12), a chemokine involved in hematopoietic cell Chemotaxis, homing, mobilization and survival, is cleaved by CD26 producing a form that is inactive in CXCR4 signaling and has some antagonistic properties in vitro. Recent studies have shown that the inhibition of cell-surface CD26 peptidase activity on hematopoietic stem/progenitor cell (HSC/HPC) populations increases their SDF-1/CXCL12 directed chemotaxis in vitro, and in vivo homing and engraftment. CD26 inhibition may, therefore, represent a novel approach to increasing the efficacy and success of HSC/HPC transplantation, especially under conditions of limiting donor cell yield.",
keywords = "CD26, CXCL12, CXCR4, Hematopoietic stem cells, Review, SDF-1, Transplantation",
author = "Campbel, {Timothy B.} and Hal Broxmeyer",
year = "2008",
doi = "10.2741/2800",
language = "English",
volume = "13",
pages = "1795--1805",
journal = "Frontiers in Bioscience - Landmark",
issn = "1093-9946",
publisher = "Frontiers in Bioscience",
number = "5",

}

TY - JOUR

T1 - CD26 inhibition and hematopoiesis

T2 - A novel approach to enhance transplantation

AU - Campbel, Timothy B.

AU - Broxmeyer, Hal

PY - 2008

Y1 - 2008

N2 - Dipeptidylpeptidase IV/CD26 is expressed on the surface of various cell types. Through its enzymatic activity, its major function is to cleave the N-terminal dipeptide from diverse molecules including members of the chemokine family of cytokines. The N-terminus of these chemokines is important for activation of and binding to seven-transmembrane G-protein linked chemokine receptors, and early studies showed truncation by CD26 physiologically alters these properties of select chemokines resulting in diverse functional outcomes. Stromal-derived factor-1 (SDF-1/CXCL12), a chemokine involved in hematopoietic cell Chemotaxis, homing, mobilization and survival, is cleaved by CD26 producing a form that is inactive in CXCR4 signaling and has some antagonistic properties in vitro. Recent studies have shown that the inhibition of cell-surface CD26 peptidase activity on hematopoietic stem/progenitor cell (HSC/HPC) populations increases their SDF-1/CXCL12 directed chemotaxis in vitro, and in vivo homing and engraftment. CD26 inhibition may, therefore, represent a novel approach to increasing the efficacy and success of HSC/HPC transplantation, especially under conditions of limiting donor cell yield.

AB - Dipeptidylpeptidase IV/CD26 is expressed on the surface of various cell types. Through its enzymatic activity, its major function is to cleave the N-terminal dipeptide from diverse molecules including members of the chemokine family of cytokines. The N-terminus of these chemokines is important for activation of and binding to seven-transmembrane G-protein linked chemokine receptors, and early studies showed truncation by CD26 physiologically alters these properties of select chemokines resulting in diverse functional outcomes. Stromal-derived factor-1 (SDF-1/CXCL12), a chemokine involved in hematopoietic cell Chemotaxis, homing, mobilization and survival, is cleaved by CD26 producing a form that is inactive in CXCR4 signaling and has some antagonistic properties in vitro. Recent studies have shown that the inhibition of cell-surface CD26 peptidase activity on hematopoietic stem/progenitor cell (HSC/HPC) populations increases their SDF-1/CXCL12 directed chemotaxis in vitro, and in vivo homing and engraftment. CD26 inhibition may, therefore, represent a novel approach to increasing the efficacy and success of HSC/HPC transplantation, especially under conditions of limiting donor cell yield.

KW - CD26

KW - CXCL12

KW - CXCR4

KW - Hematopoietic stem cells

KW - Review

KW - SDF-1

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=38449095580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38449095580&partnerID=8YFLogxK

U2 - 10.2741/2800

DO - 10.2741/2800

M3 - Article

C2 - 17981668

AN - SCOPUS:38449095580

VL - 13

SP - 1795

EP - 1805

JO - Frontiers in Bioscience - Landmark

JF - Frontiers in Bioscience - Landmark

SN - 1093-9946

IS - 5

ER -